Featured Articles
-
5 Stepping Stones To The Future State Of Rare Disease Clinical Development
11/17/2023
Review five essential steps that have the potential to propel rare disease clinical development into a new era of advancement and breakthroughs.
-
Regulatory Considerations For Radiotherapeutics And Radiodiagnostics
11/2/2023
Take a deep dive into diverse radiopharmaceuticals (RPs) and how developers and promoters of RP products are grappling with a regulatory landscape that can be intricate to traverse.
-
Navigating The FDA's Draft Guidance On Psychedelic Drug Development
11/2/2023
Uncover new guidance for the development of innovative therapies in the realm of mental health and addiction treatment.
-
ePremier: More Than A Technology Platform
10/27/2023
Experience the unifying power of ePremier, which integrates Premier Research's data-driven processes, talented individuals, and valuable resources to drive innovation in the field of biotechnology.
-
Expert Solutions From Concept To Commercialization
10/19/2023
Get the assistance your teams need to translate exceptional concepts and groundbreaking science into transformative treatments that bring hope to those facing unmet medical needs.
-
When And How To Use ODD For Orphan Subsets
10/19/2023
Learn to develop customized and tailored strategic plans, mitigate regulatory risks, and optimize marketing success when securing Orphan Drug Designation.
-
Leveraging Tech And Clinician Review To Improve Risk Detection
10/19/2023
Learn why neuroscience therapy developers should start adopting strategies to improve data quality and assess responses using a combination of technology and expert clinician review.
-
Liquid Biopsy As A Cancer Screening Tool
10/10/2023
Delve into the significance of early cancer detection and the present state of affairs, along with crucial considerations, when it comes to developing liquid biopsy solutions for cancer screening.
-
Where Biomarkers And Gene Therapy Trials Intersect
9/21/2023
Gain insight into several pivotal aspects involving gene therapy clinical development for rare diseases, such as biomarker selections and accelerated approval methods.
-
Patient Participation Strategies In Gene Therapy Studies
9/21/2023
Securing clearance for novel treatments is complex. Here, we review pertinent information on the optimization of the benefit-risk profile, the role of volunteers, and the importance of customization.